Literature DB >> 16721834

High-density lipoprotein subfractions in normolipidemic individuals without clinical atherosclerosis lipoprotein subfractions in an adult population.

Fabio L Sodré1, Vera S Castanho, Lucia N Castilho, Silvia de Barros-Mazon, Eliana C de Faria.   

Abstract

This study evaluated the serum concentrations of lipids, lipoproteins, apolipoproteins, and high-density lipoprotein (HDL) subfractions in Brazilian adults. We analyzed the distribution of lipids in HDL2 and HDL3 in a normolipidemic population without evidence of established cardiovascular disease (CVD). A total of 93 males and 92 females, healthy and normolipidemic, volunteered to be submitted to a clinical examination, a blood collection, and to answer a questionnaire aimed at determining signs and symptoms of atherosclerotic disease. Their fasting plasma lipid, lipoproteins, apolipoproteins, and the cholesterol and triglyceride concentrations in HDL2 and HDL3, isolated by microultracentrifugation, were determined by enzymatic-colorimetric methods. The interpercentile intervals (2.5-97.5) for the population were established as being 5-18 mg/dL in men and 4-28 mg/dL in women for HDL2 cholesterol (HDL2chol) and 1-57 mg/dL in men and 2-61 mg/dL in women for HDL3 cholesterol (HDL3chol). HDL2 triglyceride levels (HDL2Tg) in men were 1-26 mg/dL and in women 2-28 mg/dL; moreover, the HDL3 triglyceride (HDL3Tg) intervals were established as 4-46 mg/dL for both sexes. The determination of reference ranges for lipids in HDL subfractions in populations without clinical atherosclerosis, is an useful tool for metabolic, diagnostic, and therapeutic approaches. We determined the intervals for HDL2chol, HDL3chol, HDL2Tg, and HDL3Tg. There were variations with sex and/or age for HDL2chol, HDL3chol, and HDL2Tg in the studied population. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16721834      PMCID: PMC6807325          DOI: 10.1002/jcla.20111

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  36 in total

1.  Fractional esterification rate of cholesterol in high density lipoprotein (HDL) can predict the particle size of low density lipoprotein and HDL in patients with coronary heart disease.

Authors:  T Ohta; K Saku; K Takata; N Nagata; K K Maung; I Matsuda
Journal:  Atherosclerosis       Date:  1997-12       Impact factor: 5.162

2.  Alterations in plasma lipids, lipoproteins and high density lipoprotein subfractions in peripheral arterial disease.

Authors:  B F Mowat; E R Skinner; H M Wilson; G C Leng; F G Fowkes; D Horrobin
Journal:  Atherosclerosis       Date:  1997-06       Impact factor: 5.162

3.  Changes in high density lipoprotein subfractions and other lipoproteins by exercise.

Authors:  E R Nye; K Carlson; P Kirstein; S Rössner
Journal:  Clin Chim Acta       Date:  1981-06-02       Impact factor: 3.786

Review 4.  Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions.

Authors:  I F Godsland; V Wynn; D Crook; N E Miller
Journal:  Am Heart J       Date:  1987-12       Impact factor: 4.749

5.  Population frequency distributions of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status, and sex hormone use: the Stanford Five City Project.

Authors:  C D Gardner; D L Tribble; D R Young; D Ahn; S P Fortmann
Journal:  Prev Med       Date:  2000-10       Impact factor: 4.018

6.  Exercise intensity: its effect on the high-density lipoprotein profile.

Authors:  T Spate-Douglas; R E Keyser
Journal:  Arch Phys Med Rehabil       Date:  1999-06       Impact factor: 3.966

7.  Do upper-body and centralized adiposity measure different aspects of regional body-fat distribution? Relationship to non-insulin-dependent diabetes mellitus, lipids, and lipoproteins.

Authors:  S M Haffner; M P Stern; H P Hazuda; J Pugh; J K Patterson
Journal:  Diabetes       Date:  1987-01       Impact factor: 9.461

8.  High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study.

Authors:  R D Abbott; P W Wilson; W B Kannel; W P Castelli
Journal:  Arteriosclerosis       Date:  1988 May-Jun

9.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

Authors:  T L Bush; E Barrett-Connor; L D Cowan; M H Criqui; R B Wallace; C M Suchindran; H A Tyroler; B M Rifkind
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

10.  Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.

Authors:  Anatol Kontush; Sandrine Chantepie; M John Chapman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-08-14       Impact factor: 8.311

View more
  2 in total

1.  Relative contributions of L-FABP, SCP-2/SCP-x, or both to hepatic biliary phenotype of female mice.

Authors:  Gregory G Martin; Danilo Landrock; Kerstin K Landrock; Philip N Howles; Barbara P Atshaves; Ann B Kier; Friedhelm Schroeder
Journal:  Arch Biochem Biophys       Date:  2015-11-02       Impact factor: 4.013

2.  Reference ranges of cholesterol sub-fractions in random healthy adults in Ouagadougou, Burkina Faso.

Authors:  Alice T C R Kiba Koumaré; Linda P L Sakandé; Elie Kabré; Issaka Sondé; Jacques Simporé; Jean Sakandé
Journal:  PLoS One       Date:  2015-01-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.